GL1X · GenesisL1 explorer

MolNFT v1 · #202251 · protein

AlphaFold monomer V2.0 prediction for lys-gingipain W83 (Q51817)

Q51817: “AlphaFold monomer V2.0 prediction for lys-gingipain W83 (Q51817)”. MolNFT v1 #202251 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
Q51817
Type
protein
Length
1,732 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x4BC59faea63ACA4315D24e40823D4B8bF16F1540
UniProt
Q51817

Structure

1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein1732—Q51817

Compared structures

  • 6I9A · Porphyromonas gingivalis gingipain K (kgp) in complex with inhibitor kyt-36 · an experimental structure of the same protein · chain A against A, TM-score 0.26
  • 4RBM · Porphyromonas gingivalis gingipain K (Kgp) catalytic and immunoglobulin superfamily-like… · an experimental structure of the same protein · chain A against A, TM-score 0.26
  • 4RBM · Porphyromonas gingivalis gingipain K (kgp) catalytic and immunoglobulin superfamily-like… · an experimental structure of the same protein · chain A against A, TM-score 0.26
  • 4TKX · Structure of protease · an experimental structure of the same protein · chain A against L, TM-score 0.26
  • 4TKX · Structure of Protease · an experimental structure of the same protein · chain A against L, TM-score 0.26
  • 5MUN · Structural insight into zymogenic latency of gingipain K from porphyromonas gingivalis. · an experimental structure of the same protein · chain A against A, TM-score 0.10
  • 4ITC · Crystal Structure Analysis of the K1 Cleaved Adhesin domain of Lys-gingipain (Kgp) from… · an experimental structure of the same protein · chain A against A, TM-score 0.09
  • 4ITC · Crystal structure analysis of the K1 cleaved adhesin domain of lys- gingipain (kgp) from… · an experimental structure of the same protein · chain A against A, TM-score 0.09

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.